PRESENTATION TITLE
Cooperative Group Trials in Thoracic Oncology

PRESENTER(S)
Thomas E. Stinchcombe, M.D.
Professor of Medicine, Division of Medical Oncology, Duke Cancer Center, Durham, North Carolina

PRESENTER BIO

Dr. Thomas E. Stinchcombe is a medical oncologist at the Duke Cancer Center in Durham, North Carolina, specializing in the treatment of lung cancer and pleural mesothelioma along with other thoracic diseases. Stinchcombe also focuses on the latest clinical trials and the development of novel treatments that are improving survival rates significantly for tough-to-treat cancers. Much of his research involves immunotherapy drugs and molecular therapies. He has received multiple grants to study novel agents such as nivolumab, bevacizumab and pembrolizumab, which are being used today for lung cancer and mesothelioma. As part of the multidisciplinary approach to treatment at Duke, Stinchcombe works closely with thoracic surgeons and radiation oncologists who also specialize in treating lung and mesothelioma cancers.

VIEWING LOCATIONS
Zoom Registration Link
LEARNING OBJECTIVES

• Describe the current role of the NCI NCTN in thoracic oncology.
• Identify the role of Alliance.
• Summarize the role of cooperative groups in career development.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.